<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:hpo ids='HP_0002020'>Gastroesophageal reflux</z:hpo> is the most important factor in the development of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>The effect of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> is commonly accepted today, but there is controversy about the role of non-<z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>With introduction of combined esophageal pH-impedance monitoring, a precise diagnostic test for acid and non-<z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> is now available </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Ninety two consecutive patients (33 women) off acid-suppressive therapy underwent diagnostic work-up for suspected <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> including upper-GI endoscopy, esophageal manometry, <z:chebi fb="8" ids="32594,32595">barium</z:chebi> swallow, and combined esophageal pH-impedance monitoring </plain></SENT>
<SENT sid="4" pm="."><plain>Patients were subdivided into three groups according to symptoms and endoscopic appearance: typical symptoms without <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (n = 28; NERD); erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (n = 52, ERD), and patients with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (n = 12, BE) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Pathologic <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> during pH-metry was found in 35.7%, 63.5%, and 75.0% for NERD, ERD, and BE patients, respectively (P = 0.022) </plain></SENT>
<SENT sid="6" pm="."><plain>Likewise, the percentage of time pH &lt; 4 rose significantly during upright, supine, and total phases </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, combined pH-impedance monitoring showed no significant difference between groups for the number of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> events and for percentage of acid bolus reflux time </plain></SENT>
<SENT sid="8" pm="."><plain>However, BE patients had significantly more non-<z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> events and a higher percentage of non-acid bolus reflux time during the supine (P = 0.043, P = 0.020, respectively), but not during the upright phase (P = 0.740, P = 0.730, respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Patients with BE are exposed to increased supine non-<z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> and to increased <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> during upright and supine phases </plain></SENT>
<SENT sid="10" pm="."><plain>This observation supports the concept that nocturnal non-<z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">acid reflux</z:e> may play a role in the pathogenesis of BE </plain></SENT>
</text></document>